The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Interactions Between the Intestinal Microbiome and Liver Diseases
Open accessAbstract
The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of its homeostasis can result in disease. We review factors that disrupt intestinal homeostasis and contribute to nonalcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, and cirrhosis. Liver disease has long been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. Extrinsic factors, such as the Western diet and alcohol, contribute to these changes. Dysbiosis results in intestinal inflammation, a breakdown of the intestinal barrier, and translocation of microbial products in animal models. However, the contribution of the intestinal microbiome to liver disease goes beyond simple translocation of bacterial products that promote hepatic injury and inflammation. Microbial metabolites produced in a dysbiotic intestinal environment and host factors are equally important in the pathogenesis of liver disease. We review how the combination of liver insult and disruptions in intestinal homeostasis contribute to liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the impact of changes to the composition and function of the microbiome in NASH include altered bile acid metabolism and loss of integrity of the gut-vascular barrier, precipitating leakage of LPS and bacteria into the liver via the portal circulation (14–16).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“Changes in gut microbiota (dysbiosis) may play a key role in the pathogenesis of NAFLD/NASH and cholestasis52–54 and may also impact on BA composition and signalling.51 55”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [54]
In the citing paper
“However, a failing gut barrier and alterations of the gut microbiota in chronic liver disease (CLD) contribute to chronic inflammation and the progression of liver diseases12, and thereby increase risk for the development of hepatocellular carcinoma (HCC) as the final stage of the disease process 13–15.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Cited by
Sorted by citations
Items 401–500 of 974
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification
Panasevich, M. R., Peppler, W. T., Oerther, D. B., Wright, D. C., & Rector, R. S. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00012.2017 · Cited by 35
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35
Skubic, C., Drakulić, Ž., & Rozman, D. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1492552 · Cited by 36
Li, F., Zhao, C., Shao, T., Liu, Y., Gu, Z., Jiang, M., Li, H., Zhang, L., Gillevet, P. M., Puri, P., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5531 · Cited by 34
Gut microbiota mediated molecular events and therapy in liver diseases
Qi, X., Yang, M. J., Stenberg, J., Dey, R., Fogwe, L., Alam, M. S., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i48.7603 · Cited by 34
Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
Shao, Q., Wu, Y., Ji, J., Xu, T., Yu, Q., Ma, C., Liao, X., Cheng, F., & Wang, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.711835 · Cited by 32
Combination therapy: New hope for alcoholic hepatitis?
Gao, B., & Shah, V. H. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.008 · Cited by 33
Bhatt, B. D., Lukose, T., Siegel, A. B., Brown, R. S., & Verna, E. C. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.050 · Cited by 33
Hypothesis: solid tumours behave as systemic metabolic dictators
Lee, Y., Chang, W., & Ma, W. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12794 · Cited by 35
Implication of the intestinal microbiome in complications of cirrhosis
Bhat, M., Arendt, B. M., Bhat, V., Renner, E. L., Humar, A., & Allard, J. P. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i27.1128 · Cited by 36
The CF gastrointestinal microbiome: Structure and clinical impact
Rogers, G. B., Narkewicz, M. R., & Hoffman, L. R. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23544 · Cited by 35
Shin, H. (2019) · Journal of Periodontology · doi:10.1002/jper.19-0291 · Cited by 33
Shen, S., Zhong, T., Peng, C. Y., Fang, J., & Lü, B. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2835-7 · Cited by 33
Lee, P., Hsieh, Y.-C., Huo, T., Yang, U., Lin, C., Li, C., Huang, Y., Hou, M., Lin, H., & Lee, K. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000937 · Cited by 34
Role of Intestinal Microbes in Chronic Liver Diseases
Xu, M., Luo, K., Li, J., Li, Y., Zhang, Y., Yuan, Z., Xu, Q., & Wu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012661 · Cited by 34
Carr, R. M., Li, Y., Chau, L., Friedman, E. S., Lee, J., Adorini, L., Erickson, M., Zaru, L., Shringarpure, R., MacConell, L., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000474 · Cited by 34
Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
Zhao, Q., Wu, J., Ding, Y., Pang, Y., & Jiang, C. (2023) · Life Metabolism · doi:10.1093/lifemeta/load032 · Cited by 31
Wang, M., Zhang, X., Yan, C., He, C., Li, P., Chen, M., Su, H., & Wan, J. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.012 · Cited by 32
Tyakht, A., Manolov, A. I., Kanygina, A. V., Ischenko, D. S., Kovarsky, B. A., Popenko, A., Pavlenko, A. V., Elizarova, A., Rakitina, D. V., Baikova, I. P., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5306-5 · Cited by 33
Arreguin-Nava, M. A., Graham, D. B., Adhikari, B., Agnello, M., Selby, C. M., Hernández-Velasco, X., Vuong, C. N., Solís-Cruz, B., Hernández‐Patlan, D., Latorre, J. D., et al. (2019) · Poultry Science · doi:10.3382/ps/pez544 · Cited by 32
The Microbiome and Hepatocellular Carcinoma
Rattan, P., Minacapelli, C. D., & Rustgi, V. K. (2020) · Liver Transplantation · doi:10.1002/lt.25828 · Cited by 32
Yang, Z., Xia, Q., Lü, D., Yue, H., Zhang, J., Li, Y., Zhang, B., Li, X., & Cao, M. (2020) · Aging · doi:10.18632/aging.103962 · Cited by 32
Lu, Y., Chen, W., Song, K., Han, C. L., Gandhi, C. R., Lim, K., & Wu, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176106 · Cited by 32
Komine, S., Akiyama, K., Warabi, E., Oh, S., Kuga, K., Ishige, K., Togashi, S., Yanagawa, T., & Shoda, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12358-8 · Cited by 31
Agiasotelli, D., Alexopoulou, A., Vasilieva, L., Hadziyannis, E., Goukos, D., Daikos, G. L., & Dourakis, S. P. (2017) · Liver International · doi:10.1111/liv.13264 · Cited by 31
Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
Houben, T., Brandsma, E. T., Walenbergh, S. M. A., Hofker, M. H., & Shiri‐Sverdlov, R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.008 · Cited by 32
Alcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease
Ganesan, M., New‐Aaron, M., Dagur, R. S., Makarov, E., Wang, W., Kharbanda, K. K., Kidambi, S., Poluektova, L. Y., & Osna, N. A. (2019) · Biomolecules · doi:10.3390/biom9120851 · Cited by 31
Zhang, Y., Jiang, W., Xu, J., Wu, N., Wang, Y., Lin, T., Liu, Y., & Liu, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.535940 · Cited by 32
Zhang, F., Jin, H., Wu, L., Shao, J., Wu, X., Lu, Y., & Zheng, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.018 · Cited by 31
Moran, C. P., Sheehan, D., & Shanahan, F. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000157 · Cited by 31
Lu, Y., Wu, Y., Chen, X., Yang, X., & Xiao, H. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.128536 · Cited by 30
Paratore, M., Santopaolo, F., Cammarota, G., Pompili, M., Gasbarrini, A., & Ponziani, F. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122605 · Cited by 31
Nie, W., Du, Y., Xu, F., Zhou, K., Wang, Z., Al‐Dalali, S., Wang, Y., Li, X., Ma, Y., Xie, Y., et al. (2021) · Food & Function · doi:10.1039/d1fo01693h · Cited by 30
Lin, Y., Chen, H., Cao, Y.-J., Zhang, Y., Li, W., Guo, W., Lv, X., Rao, P., Ni, L., & Liu, P. (2021) · Foods · doi:10.3390/foods10102436 · Cited by 30
Hu, X., Wang, T., Liang, S., Li, W., Wu, X., & Jin, F. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6753-4 · Cited by 32
Relevance and consequence of chronic inflammation for obesity development
Rück, L., Wiegand, S., & Kühnen, P. (2023) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-023-00170-6 · Cited by 35
Rauth, S., Malafa, M. P., Ponnusamy, M. P., & Batra, S. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.005 · Cited by 29
Risk factors for progression of and treatment options for NAFLD in children
Hartmann, P., & Schnabl, B. (2018) · Clinical Liver Disease · doi:10.1002/cld.685 · Cited by 29
Self-citationOf mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
Green, C., Marjot, T., Tomlinson, J., & Hodson, L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13592 · Cited by 29
Wei, J., Gao, H., Yang, Y., Liu, H., Yu, H., Chen, Z., & Dong, B. (2020) · Animal Microbiome · doi:10.1186/s42523-020-00048-2 · Cited by 28
Oral Sub-Chronic Ochratoxin a Exposure Induces Gut Microbiota Alterations in Mice
Izco, M., Vettorazzi, A., de Toro, M., Sáenz, Y., & Alvarez‐Erviti, L. (2021) · Toxins · doi:10.3390/toxins13020106 · Cited by 29
Kassa, Y., Million, Y., Gedefie, A., & Moges, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s305901 · Cited by 29
Chen, S., He, Z., Wei, X., Chen, X., Lin, Z., Ma, J., Liu, Z., Yang, S., & Wang, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154121 · Cited by 29
Xu, L., Li, W., Chen, S., Deng, X.-W., Deng, W.-F., Liu, G., Chen, Y., & Cao, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1053718 · Cited by 29
Tang, Y., Zhou, H., Xiang, Y., & Cui, F. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001978 · Cited by 28
Wang, L., Liu, H., Zhou, L., Zheng, P., Li, H., Zhang, H., & Liu, W. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s468420 · Cited by 28
Zhang, L., Zhang, Z., Liu, B., Jin, Y., Tian, Y., Xin, Y., & Duan, Z. (2017) · Molecular Medicine · doi:10.2119/molmed.2017.00078 · Cited by 28
Su, Q.-Q., Tian, Y., Liu, Z., Ci, L., & Lv, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.012 · Cited by 28
Liver-related effects of chronic hepatitis C antiviral treatment
Laursen, T. L., Sandahl, T. D., Kazankov, K., George, J., & Grønbæk, H. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i22.2931 · Cited by 28
Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease
Kwong, E. K., & Puri, P. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.02.18 · Cited by 28
The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies
Lücke, J., Sabihi, M., Zhang, T., Bauditz, L. F., Shiri, A. M., Giannou, A. D., & Huber, S. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00854-z · Cited by 28
Gupta, H., Kim, S. H., Kim, S. K., Han, S. H., Kwon, H. C., & Suk, K. T. (2022) · Microorganisms · doi:10.3390/microorganisms10071474 · Cited by 30
Umemura, T., Sekiguchi, T., Joshita, S., Yamazaki, T., Fujimori, N., Shibata, S., Ichikawa, Y., Komatsu, M., Matsumoto, A., Shums, Z., et al. (2016) · Liver International · doi:10.1111/liv.13316 · Cited by 28
Maintenance of Intestinal Epithelial Homeostasis by Zinc Transporters
Ohashi, W., Hara, T., Takagishi, T., Hase, K., & Fukada, T. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05561-2 · Cited by 28
Dong, Y., Zhang, Y.-P., Jiang, X., Xie, Z.-Y., Li, B., Jiang, N.-H., Chen, S., & Lv, G. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155816 · Cited by 28
Microbiota, natural products, and human health: exploring interactions for therapeutic insights
Qadri, H., Shah, A. H., Almilaibary, A., & Mir, M. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371312 · Cited by 31
Liver Cirrhosis: The Immunocompromised State
Rodríguez-Negrete, E. V., Gálvez-Martínez, M., Sánchez-Reyes, K., Fajardo-Felix, C. F., Pérez-Reséndiz, K. E., Madrigal‐Santillán, E., Morales‐González, Á., & Morales‐González, J. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185582 · Cited by 30
Nie, Y., Zhou, W., Niu, T., Mao, M., Zhan, Y., Li, Y., Wang, K., Li, M., & Ding, K. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01454-x · Cited by 30
Fernández-Murga, M. L., Petrov, P., Conde, I., Castell, J. V., Gómez‐Lechón, M. J., & Jover, R. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.017 · Cited by 29
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 27
The liver-gut-axis: initiator and responder to sepsis
Bauer, M. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000921 · Cited by 28
Advancements in the Alcohol-Associated Liver Disease Model
Zhu, L., Li, H.-D., Xu, J., Li, J., Cheng, M., Meng, X., Huang, C., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12081035 · Cited by 30
Small-intestinal or colonic microbiota as a potential amino acid source in animals
Bergen, W. G. (2014) · Amino Acids · doi:10.1007/s00726-014-1875-z · Cited by 28
Wang, H., Liu, S., Wang, Y., Chang, B., & Wang, B. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.699 · Cited by 27
Development and Regression of Cirrhosis
Saffioti, F., & Pinzani, M. (2016) · Digestive Diseases · doi:10.1159/000444550 · Cited by 27
Bioactive metabolites: A clue to the link between MASLD and CKD?
Chen, W., Zhang, J.-H., Chen, L., Byrne, C. D., Targher, G., Luo, L., Ni, Y., Zheng, M., & Sun, D. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0782 · Cited by 27
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
Hauff, P., Gottwald, U., & Ocker, M. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.997874 · Cited by 27
de Sant’Ana, L. P., Ribeiro, D. J. S., Martins, A. M. A., dos Santos, F. N., Corrêa, R., Almeida, R. D. N., Eberlin, M. N., Maurice, C. F., & Magalhães, K. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02926 · Cited by 26
Yan, S., Khambu, B., Chen, X., Dong, Z., Guo, G. L., & Yin, X. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.10.011 · Cited by 26
Patel, D. N., Sharma, D., & Mandal, P. (2022) · Mediators of Inflammation · doi:10.1155/2022/4230599 · Cited by 26
Fructose and liver function – is this behind nonalcoholic liver disease?
Jin, R., & Vos, M. B. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000203 · Cited by 28
What can microfluidics do for human microbiome research?
Tan, H. Y., & Toh, Y. (2020) · Biomicrofluidics · doi:10.1063/5.0012185 · Cited by 26
Liu, J., Xu, Y., & Jiang, B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.586427 · Cited by 25
Yang, Y. M., Zhou, Z., Liu, Y., Xu, X., Xu, Y., Zhou, W., Chen, S., & Ma, D. (2022) · Foods · doi:10.3390/foods11111537 · Cited by 26
Chen, Z., Han, S., Zheng, P., Zhang, J., Zhou, S., & Jia, G. (2022) · Particle and Fibre Toxicology · doi:10.1186/s12989-022-00484-9 · Cited by 25
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
Hyun, J. Y., Kim, S. K., Yoon, S. J., Lee, S. B., Jeong, J., Gupta, H., Sharma, S. P., Oh, K., Won, S., Kwon, G.-H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158749 · Cited by 25
Marascio, N., Scarlata, G. G. M., Romeo, F., Cicino, C., Trecarichi, E. M., Quirino, A., Torti, C., Matera, G., & Russo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119307 · Cited by 25
Gut microbiota and immune alteration in cancer development: implication for immunotherapy
Lau, H. C.-H., Zhang, X., & Yu, J. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100007 · Cited by 24
Mechanisms coupling lipid droplets to MASLD pathophysiology
Reid, M. V., Fredrickson, G., & Mashek, D. G. (2024) · Hepatology · doi:10.1097/hep.0000000000001141 · Cited by 26
The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure
Kim, S. E., Park, J. W., Kim, H. S., Jang, M. K., Suk, K. T., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111680 · Cited by 24
Said, I., Ahad, H., & Said, A. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i5.947 · Cited by 27
Chen, X.-F., Zhang, J., Li, R., Zhang, H., Sun, Y., Jiang, L., Wang, X., & Xiong, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1034031 · Cited by 24
Lou, Z., Jun-wei, W., Chen, Y., Xu, C., Chen, X., Shao, T., Zhang, K., & Pan, H. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20197628 · Cited by 24
Yu, J. C.-K., Hale, V. L., Khodadadi, H., & Baban, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133125 · Cited by 24
Lara, C., & Romero‐Gómez, M. (2024) · European Cardiology Review · doi:10.15420/ecr.2023.34 · Cited by 22
Song, Y., Li, N., Jiang, S., Wang, K., Lv, G., Fan, Z., Du, X., Gao, W., Lei, L., Wang, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57574-3 · Cited by 25
Okubo, H., Nakatsu, Y., Sakoda, H., Kushiyama, A., Fujishiro, M., Fukushima, T., Matsunaga, Y., Ohno, H., Yoneda, M., Kamata, H., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00198.2014 · Cited by 23
Kahn, J., Pregartner, G., & Schemmer, P. (2020) · Nutrients · doi:10.3390/nu12082461 · Cited by 24
Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
Fernández-Cantos, M. V., García-Morena, D., Iannone, V., El-Nezami, H. S., Kolehmainen, M., & Kuipers, O. P. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1879719 · Cited by 23
Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection
Inoue, T., Funatsu, Y., Ohnishi, M., Isogawa, M., Kawashima, K., Tanaka, M., Moriya, K., Kawaratani, H., Momoda, R., Iio, E., et al. (2021) · Liver International · doi:10.1111/liv.15041 · Cited by 25
Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice
Inamine, T., Yang, A., Wang, L., Lee, K., Llorente, C., & Schnabl, B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13239 · Cited by 23
Self-citationKoch, M. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000699 · Cited by 23
Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity
Wang, L., Xu, D., Li, L., Xing, X., Liu, L., Abdelmotalab, M. I., Xiao, L., Pang, T., Huang, X., Wang, X., et al. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.08.017 · Cited by 22
Changes in the gut microbiota after hepatitis C virus eradication
Honda, T., Ishigami, M., Yamamoto, K., Takeyama, T., Ito, T., Ishizu, Y., Kuzuya, T., Nakamura, M., Kawashima, H., Miyahara, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03009-0 · Cited by 23
Chen, X., Zhang, Z., Cui, B., Jiang, A., Tao, H., Shaomin, C., & Liu, Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07368 · Cited by 23
Gut microbiota homeostasis restoration may become a novel therapy for breast cancer
Feng, Z., Xin, H.-Y., Zhang, Z., Liu, C., Yang, Z., You, H., & Xin, H.-W. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01063-z · Cited by 22
The Gut Microbiota in Liver Transplantation Recipients During the Perioperative Period
Lai, Z., Chen, Z., Zhang, A., Niu, Z., Cheng, M., Huo, C., & Xu, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.854017 · Cited by 22
Lee, P., Lee, K., Yang, T., Lu, H., Cheng, T.-Y., Chen, Y.-J., Chiou, J.-J., Huang, C.-W., Yang, U., Tan, E. C., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100619 · Cited by 22
Self-citationDas, B. K. (2022) · Apmis · doi:10.1111/apm.13282 · Cited by 25
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Sanyal, A. J., Gao, B., & Szabó, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.015 · Cited by 22
Metadata
- Authors
- Schnabl, B., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1513-1524
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3996054
- OpenAlex
- W1975691929
- Cited by
- 971
- References
- 86
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 88 · 2023: 101 · 2022: 88 · 2021: 92 · 2020: 102 · 2019: 88 · 2018: 89 · 2017: 58 · 2016: 64 · 2015: 77 · 2014: 31
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (U01 AA021856, R01 AA020703, 2 P42 ES010337, K08 DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- gut microbiota, gut-liver axis, non-alcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, liver cirrhosis, dysbiosis, intestinal homeostasis, intestinal barrier dysfunction, intestinal inflammation, microbial translocation, microbial metabolites, Western diet, alcohol
- MeSH terms
- Animals, Bacteria, Bile Acids and Salts, Fatty Liver, Humans, Intestines, Liver Cirrhosis, Liver Diseases, Liver Diseases, Alcoholic, Risk Factors, Host-Pathogen Interactions, Microbiota, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
